Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000897069-23-000105
Filing Date
2023-02-14
Accepted
2023-02-14 11:36:34
Documents
1

Document Format Files

Seq Description Document Type Size
1 khs7.htm SC 13G/A 44216
  Complete submission text file 0000897069-23-000105.txt   45802
Mailing Address 228 PARK AVENUE S. #66643 NEW YORK NY 10003
Business Address 228 PARK AVENUE S. #66643 NEW YORK NY 10003 (516) 962-3186
Cambrian BioPharma Inc (Filed by) CIK: 0001797409 (see all company filings)

EIN.: 842985609 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 620 PROFESSIONAL DRIVE GAITHERSBURG MD 20879
Business Address 620 PROFESSIONAL DRIVE GAITHERSBURG MD 20879 (240) 243-8000
Sensei Biotherapeutics, Inc. (Subject) CIK: 0001829802 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-92222 | Film No.: 23624872
SIC: 2834 Pharmaceutical Preparations